Core Insights - The stock price of Aosaikang has increased by 2.04% to 17.50 CNY per share as of November 26, with a total market capitalization of 16.243 billion CNY [1] - Aosaikang's stock has risen by 39.00% year-to-date, but has seen a decline of 29.86% over the past 60 days [1] - The company reported a revenue of 1.434 billion CNY for the first nine months of 2025, reflecting a year-on-year growth of 3.57%, while net profit increased by 75.81% to 223 million CNY [2] Financial Performance - Aosaikang has distributed a total of 721 million CNY in dividends since its A-share listing, with 111 million CNY distributed over the past three years [3] - The company has seen an increase in shareholder accounts by 8.50%, totaling 30,000 as of November 10 [2] Shareholder Structure - The top ten circulating shareholders include notable funds such as Yongying Medical Innovation Mixed Fund and Everbright Healthcare Industry Mixed Fund, with significant increases in their holdings [3] - The average number of circulating shares per shareholder has decreased by 7.83% to 30,917 shares [2]
奥赛康涨2.04%,成交额4254.35万元,主力资金净流入44.71万元